We found that VHL and PBRM1 had similar mutation frequencies and the two highest mutation frequencies in patients with ccRCC were in SETD2 and BAP1, more than three times higher in the high‐risk group than in the low‐risk group (Figure 4D,E). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.